ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 5397
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
NORDIMET 17,5MG INJ SOL 12(3X4)X0,7ML PEP
0238640 EU/1/16/1124/066 nordimet.pdf nordimet.pdf L04AX03 R
NORDIMET 20MG INJ SOL 4(1X4)X0,8ML PEP
0238641 EU/1/16/1124/067 nordimet.pdf nordimet.pdf L04AX03 R
NORDIMET 20MG INJ SOL 12(3X4)X0,8ML PEP
0238642 EU/1/16/1124/068 nordimet.pdf nordimet.pdf L04AX03 R
NORDIMET 22,5MG INJ SOL 4(1X4)X0,9ML PEP
0238643 EU/1/16/1124/069 nordimet.pdf nordimet.pdf L04AX03 R
NUBEQA 300MG TBL FLM 112
0238887 EU/1/20/1432/001 nubeqa.pdf nubeqa.pdf L02BB06 R
NUBEQA 300MG TBL FLM 96
0255015 EU/1/20/1432/002 nubeqa.pdf nubeqa.pdf L02BB06 R
NULOJIX 250MG INF PLV CSL 1+1STŘ
0168399 EU/1/11/694/001 nulojix.pdf nulojix.pdf L04AA28 R
NULOJIX 250MG INF PLV CSL 2+2STŘ
0168400 EU/1/11/694/002 nulojix.pdf nulojix.pdf L04AA28 R
NYVEPRIA 6MG INJ SOL 1X0,6ML
0250226 EU/1/20/1486/001 nyvepria.pdf nyvepria.pdf L03AA13 R
OCREVUS 300MG INF CNC SOL 1X10ML
0222682 EU/1/17/1231/001 ocrevus.pdf ocrevus.pdf L04AA36 R
OCREVUS 300MG INF CNC SOL 2X10ML
0222683 EU/1/17/1231/002 ocrevus.pdf ocrevus.pdf L04AA36 R
ODOMZO 200MG CPS DUR 10X1
0210977 EU/1/15/1030/001 odomzo.pdf odomzo.pdf L01XJ02 R
ODOMZO 200MG CPS DUR 30X1
0210978 EU/1/15/1030/002 odomzo.pdf odomzo.pdf L01XJ02 R
OFEV 150MG CPS MOL 60X1
0210305 EU/1/14/979/004 ofev.pdf ofev.pdf L01EX09 R
OFEV 150MG CPS MOL 30X1
0210304 EU/1/14/979/003 ofev.pdf ofev.pdf L01EX09 R
OFEV 100MG CPS MOL 60X1
0210303 EU/1/14/979/002 ofev.pdf ofev.pdf L01EX09 R
OFEV 100MG CPS MOL 30X1
0210302 EU/1/14/979/001 ofev.pdf ofev.pdf L01EX09 R
OGIVRI 150MG INF PLV CSL 1
0238289 EU/1/18/1341/001 ogivri.pdf ogivri.pdf L01FD01 R
OGIVRI 420MG INF PLV CSL 1
0249627 EU/1/18/1341/002 ogivri.pdf ogivri.pdf L01FD01 R
OLUMIANT 2MG TBL FLM 14 I
0219345 EU/1/16/1170/001 olumiant.pdf olumiant.pdf L04AA37 R

‹‹ ‹ 100 140 150 160 170 180 188 189 190 191 192 193 194 195 196 197 198 200 210 220 230 240 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 10. August 2022 at 01:08
Last update of price and payment data: 30. July 2022 at 01:10